Form D · Biotechnology
MED EDGE LLC
Ridgefield, CT · CIK 0001137582
Offering snapshot reported Dec 31, 2015 · SEC filing
- Reported sold
- $1.32M Offering amount: $1.54M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $7.21K Reported outside-investor minimum
- First sale
- Dec 15, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2015 | Initial | $1,320,639 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05, 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254247
Source: Form D, filed Dec 31, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Sfondrini | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
35 South Ridge Court
Ridgefield, CT, 06877
Ridgefield, CT, 06877